This overall average calorie intake, the paper notes, exceeds expert recommendations for individuals on GLP-1RAs (typically 1,2001,500 kcal/day for females and 1,5001,800 kcal/day for males)
I also consider GLP-1s for individuals with visceral fat accumulation, signs of insulin resistance, fatty liver or inflammatory conditions, so even in those who appear lean externally but have internal metabolic or inflammatory imbalances." However, Dr
Oral supplementation can help fill the gap
The Food and Drug Administration (FDA) has approved both drugs for weight management in adults with: a body mass index (BMI) of 30 or higher (obesity) a BMI of 27 or higher (overweight) plus at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol Wegovy also has the following approved uses: Cardiovascular health: Wegovy is approved to reduce the risk of major heart-related events like heart attack or stroke in adults with known heart disease who have obesity or are overweight